Ranjana B. Pathak, BSc, MBA, DHA Cipla Limited

Dr. Ranjana Pathak is President - Global Quality, Medical Affairs & Pharmacovigilance at Cipla. Ranjana has previously held leadership roles in pharmaceutical companies such as Actavis, Endo Pharmaceuticals, Zenith Goldline, Dupont-Merck, and Thames Pharmacol.

Ranjana has a Doctorate in Health Administration from the University of Phoenix, USA; an MBA from Dowling College, New York; a Post-Graduate Diploma in Pharmaceutical & Chemical Analysis from Sophia College, Mumbai; and a B.Sc. (Hons) in Chemistry from Mithibai College, Mumbai. She has received training in leadership in pharmaceuticals and biologics at Harvard University.

As a Member of the Management Council at Cipla, Ranjana leads the organisation’s worldwide quality enterprise from the development of a product to its commercialization, and spearheads Cipla’s commitment to an uncompromising state of control with absolute regulatory compliance across all manufacturing sites of Cipla, its partners and third parties.

An industry veteran, Ranjana has over three decades of experience in pharma and brings to the table extensive industry experience in dealing with regulatory bodies around the world.

In 2006, Ranjana received the Rising Star award - Healthcare Business Association. In 2018, Woman Leader of the Year award -Future Leaders’ Summit. In 2019, National Healthcare Leadership Women Award - Zee Business.